|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
|
Fig. 3. Fgf9 signals through mesenchymal receptors to drive small intestine
development/elongation. (A) Section of an E14.5
Dermo1-cre; Rosa26R small intestine stained with X-Gal. The
epithelium, mesenchyme and muscularis propria are indicated. Blue staining
showed regions of Dermo1-cre activity in all cells in the mesenchyme and
muscularis propria. The epithelial compartment showed no detectable staining.
(B) Section of an E18.5 Dermo1-cre; Rosa26R small intestine
stained with anti-β-galactosidase and anti-Pecam (red, top) or CD45 (red,
bottom). Both cells show colocalization of punctuate β-galactosidase with
the cell lineage markers. No detectable β-galactosidase staining was
detected in the epithelium. (C) PCR products of DNA that was procured
from the epithelium and mesenchyme of control and DCR1R2 E18.5 small
intestines. The recombined alleles of Fgfr1 and Fgfr2 were detected in the
mesenchyme of DCR1R2 mice but not in the epithelium. PCR of vimentin
is shown as a control for the isolation of the DNA. (D) Quantification
of the means of the small intestinal lengths (±s.d. normalized to
wild-type length; n=4-5 mice/group) in mice with loss of mesenchymal
Fgfr1 (DCR1), Fgfr2 (DCR2), and both Fgfr1 and Fgfr2
(DCR1R2). Loss of both Fgfrs was additive. Two asterisks indicate
statistically significant differences when comparing any two groups (Student's
t-test, P<0.01). (E) Quantification of S-phase
cells in three cellular compartments (intervillus epithelium, mesenchyme and
muscularis propria) of E18.5 control and DCR1R2 small intestines.
Mean±s.d. for each group is plotted. Statistically significant
differences in the means are denoted by an asterisk (P<0.05 by
Student's t-test). Scale bars: 10 µm in A; 5 µm in B.
|
